Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Geldmacher C et al. - TL9 variant cross-recognition properties were extensive in B81+ subjects, but limited in B42+ subjects. Thus, minor viral and host genetic polymorphisms can dramatically alter the immunological and virological outcome of an epitope-specific CD8 T cell response.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address